EXAGEN INC. (XGN) › Shareholders' EquityEXAGEN INC. (XGN) — Shareholders' EquityAnnual figures by period end, from SEC filings.2017-12-31: -$96.68M2018-12-31: -$111.97M2019-12-31: $55.66M2020-12-31: $41.84M2021-12-31: $84.94M2022-12-31: $42.46M2023-12-31: $22.69M2024-12-31: $9.54M2025-12-31: $17.45M$17.45M2017-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$17.45M+82.9%2026-03-10Balance as of period end2024-12-31$9.54M-58.0%2026-03-10Balance as of period end2023-12-31$22.69M-46.6%2026-03-10Balance as of period end2022-12-31$42.46M-50.0%2025-03-11Balance as of period end2021-12-31$84.94M+103.0%2024-03-18Balance as of period end2020-12-31$41.84M-24.8%2023-03-20Balance as of period end2019-12-31$55.66M—2022-03-22Balance as of period end2018-12-31-$111.97M—2021-03-16Balance as of period end2017-12-31-$96.68M—2020-03-25Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)